About Alector (ALEC)
Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologi... Read more
- USD6.57
- USD6.63
- USD6.33
- USD9.07
- 48.90%
- 96M
- 603.81k
- 582.21k
- 562M
- 3.66
- 4.20%
Stock News
5 hours ago
1 Wall Street Analyst Thinks Tesla Stock Is Going to $258. Is It a Buy After a Post-Earnings Pullback?
Yahoo
7 hours ago
Warren Buffett Is in a Selling Mood. What’s Next?
Yahoo
7 hours ago
Weekly Market Outlook: Central Banks And U.S. Earnings. Will The BoJ Hike Rates?
SeekingAlpha
yesterday
Ackman’s Pershing Square USA says IPO is still happening, despite NYSE delay notice
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
